With the slowdown in world economic growth, the Enteral Nutrition industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Enteral Nutrition market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2018, Stratagem Market Insights analysts believe that in the next few years, Enteral Nutrition market size will be further expanded, we expect that by 2023, The market size of the Enteral Nutrition will reach XXX million $.
Overview
Enteral Nutrition is typically used to administer various drugs or nutrients. However, there are other uses for Enteral Nutrition that include administering analgesics, chemotherapy agents, steroids, fluids, electrolytes, and many other specialized nutrients and medications. Enteral Administration is also commonly used to administer meals and is also sometimes used for the treatment of diarrhea. In general, most enteric coatings provide excellent penetration rates, allowing nutrients to be absorbed quickly and entering the bloodstream. The primary method of delivering Enteral Nutrition is through the use of a specialized tube called an Enteric Nucer, which is inserted into the stomach via a thin tube. Unlike most tubes used for fluid therapy, and Enteric Nucer does not require a needle to insert - this reduces infections and any potential for damage to internal organs, especially those near the mouth. The global enteral nutrition market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global enteral nutrition market is expected to witness significant growth during the forecast period, owing to increasing prevalence of chronic diseases.
Market Drivers
Increasing incidence of preterm births is expected to drive growth of the global enteral nutrition market during the forecast period. According to the World Health Organization (WHO), every year around 15 million babies are born preterm, which is before 37 completed weeks of gestation. This, in turn, has increased the demand for enteral nutrition worldwide. Hence, such factors are expected to drive growth of the global enteral nutrition market during the forecast period. Moreover, increasing prevalence of chronic diseases is expected to propel the global enteral nutrition market growth over the forecast period.
Market Restraints
Complications associated with enteral feeding devices are expected to hinder the global enteral nutrition market growth over the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global enteral nutrition market during the forecast period. This is owing to rapidly increasing geriatric population in the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to improving healthcare infrastructure in the region.
Competitive Section
Key companies involved in the global enteral nutrition market are Abbott Laboratories, Fresenius Kabi, Nestlé, B. Braun Melsungen, Mead Johnson Nutrition, and Danone.
For instance, in June 2020, Otsuka Pharmaceutical Factory Inc. launched a new ENORAS Liquid for Enteral use.
This Report covers the manufacturers' data, including shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume, and value, as well as price data.
Besides, the report also covers segment data, including type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
Abbott Laboratories
Nestlé
Danone
Fresenius Kabi
Mead Johnson Nutrition
B. Braun Melsungen
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Standard Protein diet
High Protein Supplement
Protein for Diabetes Care Patient
Industry Segmentation
Hospital Sale
Retail
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2018-2023)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
